Quick Links


    Print

AIDS Vaccine Conference 2011  

Where: Bangkok, Thailand

When: September 12 - September 15, 2011

AIDS Vaccine 2011 will provide an interactive forum for the participation of leaders and future leaders in the HIV vaccine field—policymakers and funders, multidisciplinary and highly specialized researchers, promising and talented young scientists, public-health experts, clinicians, epidemiologists, representatives of community associations and community advocates, and members of the private HIV vaccine-development sector—thereby fostering and strengthening a collaborative global network and a global research environment.

The final program is now available here.

For those of you unable to attend in person, there are a number of ways to follow the conference remotely. AVAC and others will be tweeting real-time updates from Bangkok (follow AVAC @hivpxresearch and/or follow #aidsvax11 on Twitter). The conference organizers have also organized webcasts of plenary sessions and press conferences. Session webcasts will be posted the next day—check them out on the conference website or AVAC’s Facebook page.

Photos from the conference may be seen below.

Webcasts of selected sessions are available here.

For further information, visit the conference website: www.vaccineenterprise.com/conference/2011.


The following are satellite sessions that may be of interest:

An AIDS-Free Africa Through an Effective Vaccine - Prospects, Progress, and Challenges
Monday, September 12
8:30 - 10:30
Lotus 1-2, Level 22
Open Session

Host Institutions: The African AIDS Vaccine Partnership (AAVP), The Global Vaccine Enterprise, and AVAC

Session Chairs: Dr. Alash’le Abimiku, Dr. Saladin Osmanov

The AAVP satellite meeting aims to bring together all stakeholders attending the conference to critically appraise the progress towards an AIDS vaccine that can be used in Africa. The overall goal is to identify gaps in Africa’s response to HIV vaccine R&D, with the following objectives:

1. Provide a forum for engagement of scientists and community activists with a view to identifying obstacles to effective participation of African stakeholders in HIV vaccine R&D.
2. Disseminate AAVP’s new strategic direction and plans to all stakeholders, and seek input of participants on ways of enhancing the AAVP’s relevance to the different stakeholders.


Gathering Sexual Risk Information in HIV Biomedical Prevention Trials—An Offering of Best Practices
Monday, September 12
12 - 15:30
Lotus Suite 3

Click here for more information.


Moving Forward Together: Research Literacy and Community Engagement in 2011 and Beyond
Monday, September 12
8:30-15:30
Lotus 7, Level 22
Open Session

A flyer is available.

Host Institutions: Thai NGO Coalition on AIDS (TNCA), AVAC, HVTN, IAVI, UNAIDS and US Military HIV Research Program-Armed Forces Research Institute of Medical Sciences

Session Chairs: Udom Likhitwonnawut, Nusara Thaitawat

This satellite will include interactive capacity-building sessions, panels and roundtable discussions that will provide advocates, researchers and community stakeholders an opportunity to identify key issues in the evolving research agenda and provide context for the conference.

UPDATE: Photos from the session below.

AVAC: Global Advocacy for HIV Prevention
101 West 23rd Street   ·  New York, NY  
+1 212.796.6423 (main)   ·  avac@avac.org
Copyright 2012, All rights reserved.
Design by Lomangino Studio | Powered by Orchid Suites Orchid ver. 4.7.6.